Hong Kong stock market anomaly | Keji Pharmaceutical-B(02171.HK) rises by more than 7% again. Clinical research results of the treatment of multiple myeloma drugs will be released at the European EHA annual meeting.

According to the Chinese financial news app, Smart Finance, Keji Pharmaceutical - B (02171.HK) has risen by over 7% again, as of the time of publication, it has risen by 6.65% to 17 Hong Kong dollars, with a trading volume of 36.8529 million Hong Kong dollars.